Chardan Downgrades Regeneron To Sell
March 16, 2016 at 16:12 PM EDT
Chardan Capital Markets analyst Gbola Amusa has downgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to Sell after Amgen, Inc. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.